AVANTUS RENAL THERAPY NEW YORK, LLC
NPI: 1871925123
· NEW YORK, NY 10025
· 261QE0700X
$4.83M
Total Medicaid Paid
Monthly Spending Trend
Yearly Breakdown
| Year | Claims | Total Paid |
|---|
| 2018 |
1,163 |
$6K |
| 2019 |
13,928 |
$246K |
| 2020 |
33,360 |
$794K |
| 2021 |
15,129 |
$674K |
| 2022 |
17,109 |
$836K |
| 2023 |
17,665 |
$1.00M |
| 2024 |
20,878 |
$1.27M |
Billing Codes
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 90935 |
|
16,414 |
1,493 |
$4.58M |
| A4657 |
Syringe w/wo needle |
66,432 |
2,578 |
$232K |
| 90999 |
|
912 |
91 |
$11K |
| J0887 |
Epoetin beta esrd use |
1,934 |
1,219 |
$7K |
| J1756 |
Iron sucrose injection |
4,749 |
1,122 |
$48.04 |
| 83970 |
|
920 |
896 |
$12.34 |
| 82248 |
|
189 |
185 |
$6.50 |
| 80053 |
|
71 |
69 |
$4.15 |
| 82728 |
|
872 |
856 |
$4.07 |
| 87340 |
|
512 |
500 |
$3.08 |
| 83550 |
|
889 |
868 |
$2.61 |
| 85025 |
|
928 |
903 |
$2.32 |
| 85018 |
|
2,510 |
914 |
$2.13 |
| 83540 |
|
935 |
913 |
$1.93 |
| A6216 |
Non-sterile gauze<=16 sq in |
593 |
74 |
$1.65 |
| 84100 |
|
772 |
662 |
$1.42 |
| 84520 |
|
2,025 |
921 |
$1.18 |
| 80051 |
|
204 |
200 |
$0.00 |
| G0008 |
Admin influenza virus vac |
13 |
13 |
$0.00 |
| 82040 |
|
13 |
12 |
$0.00 |
| 86706 |
|
144 |
140 |
$0.00 |
| 86803 |
|
29 |
28 |
$0.00 |
| 83735 |
|
229 |
225 |
$0.00 |
| 82746 |
|
29 |
29 |
$0.00 |
| 84132 |
|
204 |
80 |
$0.00 |
| 82330 |
|
39 |
38 |
$0.00 |
| 80069 |
|
67 |
67 |
$0.00 |
| 82607 |
|
12 |
12 |
$0.00 |
| 84075 |
|
24 |
24 |
$0.00 |
| J1644 |
Inj heparin sodium per 1000u |
14,989 |
1,378 |
$0.00 |
| 82310 |
|
329 |
272 |
$0.00 |
| 84155 |
|
371 |
367 |
$0.00 |
| 85014 |
|
537 |
206 |
$0.00 |
| 82565 |
|
252 |
243 |
$0.00 |
| 82108 |
|
63 |
62 |
$0.00 |
| 84460 |
|
13 |
12 |
$0.00 |
| 84450 |
|
14 |
13 |
$0.00 |